Atlas Trials

Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial

Clinical trial NCT07368673 · COMPLETED

Trial details

NCT number
NCT07368673
Sponsor
Dow University of Health Sciences
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Vitiligo
Start date
2025-04-06
Primary completion
2025-12-31
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.